Historical record - last NADAC effective date: 9/18/2019
Product Information
ST. JOSEPH ASPIRIN 81 MG CHEW is a generic product labeled by Foundation Consumer Healthcare LLC, priced at $0.0276 per EA under NDC 69536028136. Its NADAC has been published 49 times since Oct 31, 2018.
Strength
81 mg/1
Manufacturer
Foundation Consumer Healthcare LLCNDC
69536028136
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
9/18/2019
Active Ingredients
ASPIRINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
2/17/2017
Pharmacological Classes
Price Statistics
The NADAC for ST. JOSEPH ASPIRIN 81 MG CHEW has been published 49 times since Oct 31, 2018, and over the history we have for it it has risen 4.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0276 per EA |
|---|---|
| All-time high | $0.0281 (Dec 12, 2018) |
| All-time low | $0.0264 (Oct 31, 2018) |
| Median price | $0.0273 |
| Average price | $0.0273 |
| Largest weekly change | +6.2% (Nov 21, 2018) |
| Weeks tracked | 49 |
| Tracking since | Oct 31, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+4.5%
Last surveyed Oct 2, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 49% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Foundation Consumer Healthcare LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ASPIRIN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ST. JOSEPH ASPIRIN 81 MG CHEW?
The current National Average Drug Acquisition Cost (NADAC) for ST. JOSEPH ASPIRIN 81 MG CHEW, manufactured by Foundation Consumer Healthcare LLC, is $0.0276 per EA (NDC 69536028136), effective Oct 2, 2019.
How has the price of ST. JOSEPH ASPIRIN 81 MG CHEW changed over time?
Over the history we have for it, the NADAC for ST. JOSEPH ASPIRIN 81 MG CHEW has risen 4.5%. It has been tracked across 49 weekly CMS publications since Oct 31, 2018.
What are the highest and lowest recorded NADAC prices for ST. JOSEPH ASPIRIN 81 MG CHEW?
Since Oct 31, 2018, the NADAC for ST. JOSEPH ASPIRIN 81 MG CHEW has ranged from a low of $0.0264 (Oct 31, 2018) to a high of $0.0281 (Dec 12, 2018), with a median of $0.0273 per EA.
Are there cheaper alternatives to ST. JOSEPH ASPIRIN 81 MG CHEW?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QC ASPIRIN EC 81 MG TABLET, is $0.0142 per EA — about 49% below ST. JOSEPH ASPIRIN 81 MG CHEW.
Who manufactures ST. JOSEPH ASPIRIN 81 MG CHEW?
ST. JOSEPH ASPIRIN 81 MG CHEW (NDC 69536028136) is labeled by Foundation Consumer Healthcare LLC, and CMS classifies it as a generic product.